Coronado Biosciences Inc (CNDO) Return on Investment ROI from the fourth quarter of 2014 to fourth quarter of and for the year 2014, average high and low, overall ranking from Dec 31 2014 to - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Coronado Biosciences Inc  (CNDO)


Coronado Biosciences Inc's ROI from its fourth quarter of 2014 to the fourth quarter of and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Coronado Biosciences Inc's ROI in the fourth quarter of 2014?
Coronado Biosciences Inc achieved a return on average invested assets (ROI) of 62.67 % in its fourth quarter of 2014, this is above CNDO's average return on investment of 0%.
Coronado Biosciences Inc invested over the 12 months ending in its fourth quarter of 2014 $44 million

ROI has improved compared to -43.85% in the fourth quarter of 2013, due to net income growth.

Within the Healthcare sector Coronado Biosciences Inc achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the fourth quarter of 2013 at no. .

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2014)
IV. Quarter		 (Dec 31 2013)
IV. Quarter


Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 85 89 0 0 0
Return On Investment (TTM) 62.67 % -43.85 % - - -
CNDO's Overall Ranking # # # # #
Seq. Investment Change TTM 95.39 % - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 27 -10 0 0 0

CNDO Company Profile >> Back to CNDO Roi Comparisons >> See Annual CNDO Return On Investment



Return On Investment CNDO's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Coronado Biosciences Inc's IV. Quarter Investments $ 85 Millions CNDO's Balance sheet
Coronado Biosciences Inc's IV. Quarter Income $ 37 Millions Quarterly CNDO's Income Statement
CNDO's Income by Division See CNDO's Income by Division


CNDO Annual Return On Investment (Dec 31 2014)
2014		 (Dec 31 2013)
2013


Total Investments in Millions 85 89 0 0 0
Y / Y Investment Growth -4.61 % - - - -
Net Income in Millions -20 -37 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -23.91 % -41.58 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CNDO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CNDO's Competitors
Subscribers only: Roi for Coronado Biosciences Inc's Suppliers
Subscribers only: Return On Investment for CNDO's Customers

Other Ratios
CNDO's Roa CNDO's Inventory Turnover Ratio CNDO's Growth Rates CNDO's Dividend Statistics
CNDO's Profitability Ratios CNDO's Asset Turnover Ratio CNDO's Dividend Growth
CNDO's Roe CNDO's Valuation Ratios CNDO's Financial Strength Ratios CNDO's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2014, within Healthcare Sector ROI
Tuhura Biosciences Inc   156.05 %
Brainstorm Cell Therapeutics inc   126.96 %
Viskase Holdings inc   122.51 %
Earth Science Tech Inc   115.12 %
Glucotrack Inc   101.88 %
Lumos Pharma Inc   89.32 %
Armata Pharmaceuticals Inc   82.89 %
Journey Medical Corp  81.25 %
Sientra Inc   78.52 %
Agile Therapeutics Inc  64.51 %
Enanta Pharmaceuticals Inc  58.30 %
Pacific Health Care Organization Inc  49.84 %
Gilead Sciences Inc   49.78 %
Generex Biotechnology Corp  49.57 %
Eyepoint Inc   48.11 %
Otonomy Inc   47.83 %
Eternity Healthcare Inc.  47.74 %
Nevro Corp   45.97 %
Astrotech Corp  40.10 %
Lannett Company Inc  39.44 %
Cryo cell International Inc   39.14 %
Iridex Corp  35.28 %
Bioage Labs Inc   34.95 %
Sunwin Stevia International Inc.  34.66 %
Lifevantage Corp  31.32 %
Scientific Industries Inc   30.41 %
Luna Innovations Inc  30.01 %
Oramed Pharmaceuticals Inc  29.73 %
Edwards Lifesciences Corporation  29.25 %
Adverum Biotechnologies Inc   26.98 %

Date modified: 2026-09-08T15:08:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.